Trends and innovations in diagnostic devices, imaging systems, and medical equipment.
Discover the latest developments in the Glucose Biosensors Market: key trends, market size, segmentation, regional analysis, growth drivers, competitive landscape, and future opportunities. Stay informed with expert insights and actionable FAQs!
Explore the Pulmonary Arterial Hypertension (PAH) market with a detailed analysis of its size, key growth drivers, emerging trends, competitive landscape, and future outlook for the period 2024-2035.
The infusion pump market is valued at about $19.9 billion in 2025 and is expected to grow at a CAGR of 7.4%, driven by tech advances and rising chronic diseases
North America led the pulmonary arterial hypertension market in 2024 with a 31.8% share, highlighting its dominance and steady growth outlook to 2035.
The At-Home Testing Market valued at around USD 14.56 Billion in 2024, reaching a valuation of US$ 32.82 billion by 2035, and is expected to expand at a CAGR of 11.5% from 2025 to 2035.
Industry analysis suggests the global infusion pump market will nearly double in value, moving from US$ 12.45 billion in 2024 to US$ 27.30 billion by 2035, supported by a 7.1% CAGR throughout 2025–2035.
The glucose biosensors market stood at USD 9.56 billion in 2024 and is expected to reach USD 24.08 billion by 3035, growing at a CAGR of 8.3%.
